Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites
- 31 December 1993
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 29 (8), 1152-1157
- https://doi.org/10.1016/s0959-8049(05)80306-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell linesBritish Journal of Cancer, 1992
- Overexpression of the MDR1 Gene and P-Glycoprotein in Human Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Biochemical and pharmacological effects of toremifene metabolitesCancer Chemotherapy and Pharmacology, 1990
- Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance.Journal of Clinical Oncology, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cellsFEBS Letters, 1989
- Intrinsic multidrug resistance phenotype of chinese hamster (rodent) cells in comparison to human cellsBiochemical and Biophysical Research Communications, 1988
- Interactions among membrane transport systems: Anthracyclines, calcium antagonists and anti-estrogensBiochemical Pharmacology, 1986
- 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growthBiochemical and Biophysical Research Communications, 1981
- Breast Tumor Cell Lines From Pleural Effusions2JNCI Journal of the National Cancer Institute, 1974